Related references
Note: Only part of the references are listed.Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease
Ju Dong Yang et al.
HEPATOLOGY (2020)
Treatment of Hepatocellular Carcinoma in the Precision Medicine Era: From Treatment Stage Migration to Therapeutic Hierarchy
Alessandro Vitale et al.
HEPATOLOGY (2020)
Epidemiology and surveillance for hepatocellular carcinoma: New trends
Amit G. Singal et al.
JOURNAL OF HEPATOLOGY (2020)
Advances in molecular classification and precision oncology in hepatocellular carcinoma
Sandra Rebouissou et al.
JOURNAL OF HEPATOLOGY (2020)
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
Giuseppe Cabibbo et al.
JOURNAL OF HEPATOLOGY (2019)
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
Vincenzo Mazzaferro et al.
GASTROENTEROLOGY (2018)
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice
Edoardo Giovanni Giannini et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
The impact of treatment of hepatitis C with DAAs on the occurrence of HCC
Bruno Roche et al.
LIVER INTERNATIONAL (2018)
Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis
Nathalie Ganne-Carrie et al.
JOURNAL OF HEPATOLOGY (2018)
Systemic Therapy for Hepatocellular Carcinoma: Latest Advances
Masatoshi Kudo
CANCERS (2018)
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma
Anna Pecorelli et al.
LIVER INTERNATIONAL (2017)
The evolutionary scenario of hepatocellular carcinoma in Italy: an update
Laura Bucci et al.
LIVER INTERNATIONAL (2017)
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome
L. Bucci et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Clinical Patterns of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease: A Multicenter Prospective Study
Fabio Piscaglia et al.
HEPATOLOGY (2016)
Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality
Do Young Kim et al.
HEPATOLOGY INTERNATIONAL (2016)
Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response
Bryony Simmons et al.
CLINICAL INFECTIOUS DISEASES (2015)
Determinants of Alpha-Fetoprotein Levels in Patients With Hepatocellular Carcinoma
Edoardo G. Giannini et al.
CANCER (2014)
Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease
Ju-Yeon Cho et al.
GUT (2014)
Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
Jessica Dyson et al.
JOURNAL OF HEPATOLOGY (2014)
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies
Rebecca L. Morgan et al.
ANNALS OF INTERNAL MEDICINE (2013)
Epidemiology of Hepatocellular Carcinoma Consider the Population
Sahil Mittal et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Surveillance for early diagnosis of hepatocellular carcinoma: How best to do it?
Edoardo G. Giannini et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
The changing scenario of hepatocellular carcinoma over the last two decades in Italy
Valentina Santi et al.
JOURNAL OF HEPATOLOGY (2012)
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Gyoergy Baffy et al.
JOURNAL OF HEPATOLOGY (2012)
The worldwide impact of vaccination on the control and protection of viral hepatitis B
Luisa Romano et al.
DIGESTIVE AND LIVER DISEASE (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus-Related Cirrhosis
Ashwani K. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Outcome of Sustained Virological Responders With Histologically Advanced Chronic Hepatitis C
Timothy R. Morgan et al.
HEPATOLOGY (2010)
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
Valentina Santi et al.
JOURNAL OF HEPATOLOGY (2010)
Metabolic Syndrome and Hepatocellular Carcinoma Two Growing Epidemics With a Potential Link
Abby B. Siegel et al.
CANCER (2009)
Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy
M Moriyama et al.
LIVER INTERNATIONAL (2005)
Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma
E Bugianesi et al.
GASTROENTEROLOGY (2002)
Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease:: influence of HBsAg and anti-HCV status
F Trevisani et al.
JOURNAL OF HEPATOLOGY (2001)
Share Paper
